$GOSS

$9.77 +$0.62 (6.78%) Close

$GOSS Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Company Executives

$GOSS Management Team

Mr. Faheem Hasnain

Chairman of the Board

President

Chief Executive Officer

Co-Founder

Age 66

Compensation $2.005M USD

Sex Male

Mr. Bryan Giraudo

Chief Operating Officer

Chief Financial Officer

Age 50

Compensation $1.172M USD

Sex Male

Ms. Caryn Peterson

Executive Vice President - Regulatory Affairs

Age 66

Compensation -

Sex Female

Mr. Christian Waage

Executive Vice President - Technical Operations and Administration

Age 58

Compensation $1.651M USD

Sex Male

Dr. Richard Aranda

Chief Medical Officer

Age 65

Compensation $1.065M USD

Sex Male

Mr. Robert Smith

Chief Commercial Officer

Age 56

Compensation $1.331M USD

Sex Male

Name / Title	Age	Compensation	Sex
Mr. Faheem Hasnain Chairman of the Board President Chief Executive Officer Co-Founder	66	$2.005M USD	Male
Mr. Bryan Giraudo Chief Operating Officer Chief Financial Officer	50	$1.172M USD	Male
Ms. Caryn Peterson Executive Vice President - Regulatory Affairs	66	-	Female
Mr. Christian Waage Executive Vice President - Technical Operations and Administration	58	$1.651M USD	Male
Dr. Richard Aranda Chief Medical Officer	65	$1.065M USD	Male
Mr. Robert Smith Chief Commercial Officer	56	$1.331M USD	Male

Board of Directors

From the proxy statement filed Apr 24, 2026

Directors

serving now

Independent

6 of 7

stated in the proxy

Average tenure

4.7 years

from year joined

CEO also chairs the board

Yes

Faheem Hasnain

Director	Age	On board	Independent	Committees	Other public boards	2025 pay
Faheem Hasnain Board chair, CEO	67	Not stated	Not independent	None stated	Kura Oncology, Inc.	Paid as CEO
Russell Cox	62	2018 8 years	Independent	audit	None stated	$186,319
Skye Drynan	50	2024 2 years	Independent	None stated	None stated	$181,444
John Quisel, Ph.D., J.D.	54	2023 3 years	Independent	audit	Disc Medicine, Inc.	$172,069
Thomas Daniel, M.D. Lead independent director	72	2018 8 years	Independent	compensation nominating and corporate governance	None stated	$199,569
Sandra Milligan, M.D., J.D.	62	2021 5 years	Independent	compensation	Spyre Therapeutics, Inc.	$179,319
Steven Nathan, M.D.	67	2024 2 years	Independent	None stated	None stated	$167,444

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

2 disclosed in the proxy filed Apr 24, 2026

Aaron Hasnain

son of our Chairman, President and Chief Executive Officer

$288,751 per year

since January 2018

Employment as VP, Business Development & Alliance at a salary.

Open in proxy

Aaron Hasnain

son of our Chairman, President and Chief Executive Officer

Amount not stated

since January 1, 2025

Grants of 220,000 options, 45,000 RSUs and 46,875 PSUs.

Open in proxy

Comments

Company Executives

$GOSS Management Team

Mr. Faheem Hasnain

Mr. Bryan Giraudo

Ms. Caryn Peterson

Mr. Christian Waage

Dr. Richard Aranda

Mr. Robert Smith

Board of Directors

Related-party transactions